Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 04, 2026 19:25 ET | Source: Robbins LLP

CHX Stockholders Have Rights – If You Lost Money Investing in ChampionX Corporation, Inc. Contact Robbins LLP for Information About Recovering Your Losses

Robbins LLP is Investigating Allegations that ChampionX Corporation (CHX) Repurchased Shares of its Stock in Violation of Securities Laws
June 03, 2026 16:09 ET | Source: Robbins LLP

Beta Bionics, Inc. Securities Fraud Investigation – Robbins LLP is Investigating Investor Losses in BBNX Due to Possible Violations of Securities Laws

Beta Bionics, Inc. Securities Fraud Investigation – Robbins LLP is Investigating Investor Losses in BBNX Due to Possible Violations of Securities Laws
June 03, 2026 15:07 ET | Source: Robbins LLP

LCID Class Action Reminder - Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Lucid Group, Inc. Securities Class Action

Robbins LLP is Investigating Allegations that Lucid Group, Inc. (LCID) Failed to Disclose Significant Supplier and Delivery Issues to Investors
June 02, 2026 19:24 ET | Source: Robbins LLP

BBNX Shareholder Alert: Robbins LLP Reminds Beta Bionics, Inc. Stockholders that it is Investigating the Company's Officers and Directors to Determine if They Violated Securities Laws and Breached Fiduciary Duties to Shareholders

BBNX Shareholder Alert: Robbins LLP Reminds Beta Bionics, Inc. Stockholders that it is Investigating the Company's Officers and Directors to Determine if T
June 02, 2026 19:18 ET | Source: Robbins LLP

SLP Shareholder Alert: Robbins LLP Reminds Simulation Plus, Inc. Stockholders that it is Investigating the Company's Officers and Directors to Determine if They Violated Securities Laws and Breached Fiduciary Duties to Shareholders

SLP Shareholder Alert: Robbins LLP Reminds Simulation Plus, Inc. Stockholders that it is Investigating the Company's Officers and Directors
June 02, 2026 08:30 ET | Source: Quoin Pharmaceuticals, Inc.

Quoin Pharmaceuticals Submits IND Application for QRX003 in Peeling Skin Syndrome

-First ever IND submission for this disease, which has no current treatment or cure- -Quoin plans Phase 2 study initiation in 2H 2026- -Submission supported by positive initial clinical data from...
May 28, 2026 09:12 ET | Source: BTCC Exchange

BTCC Exchange Launches TradFi Trading Carnival Rewarding Traders as Multi-Asset Demand Grows

LODZ, Poland, May 28, 2026 (GLOBE NEWSWIRE) -- BTCC, the world's longest-serving cryptocurrency exchange, has launched its TradFi Trading Carnival. This limited-time campaign allows traders to...
May 21, 2026 20:07 ET | Source: Robbins LLP

Robbins LLP Encourages STLA Investors to Contact the Firm for Information About the Class Action Against Stellantis N.V.

Robbins LLP is Investigating Allegations that Stellantis N.V. (STLA) Misled Investors Regarding its 2025 Earnings Projections
May 21, 2026 19:12 ET | Source: Robbins LLP

Robbins LLP Encourages UPST Investors to Contact the Firm for Information About the Class Action Against Upstart Holdings, Inc.

Robbins LLP is Investigating Allegations that Upstart Holdings, Inc. (UPST) Misled Investors Regarding its Business Prospects
May 21, 2026 18:51 ET | Source: Robbins LLP

CHX Class Action Notice: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the ChampionX Corporation Class Action Lawsuit

Robbins LLP is Investigating Allegations that ChampionX Corporation (CHX) Repurchased Shares of its Stock in Violation of Securities Laws